Position in NTRA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$14,946,652
-$1,279,334 QoQ
Shares Held
74,737
+5.5% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 95.45740396323107.ToString("F0")%
Shared 0.ToString("F0")%
None 4.542596036768937.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PARNASSUS INVESTMENTS, LLC holds $1,610,890,284 across 6 Diagnostics & Research names. NTRA ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
3,974,829 | $753,627,578 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,504,651 | $739,581,106 | |
| 3 | A |
Agilent Technologies, Inc.
|
586,689 | $66,870,812 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
32,709 | $18,378,860 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
13,864 | $17,485,276 | |
| 6 | NTRA |
Natera, Inc.
This page
|
74,737 | $14,946,652 |
All Filings in NTRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,946,652 | 74,737 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $16,225,986 | 70,828 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,983,948 | 68,236 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $11,766,164 | 69,647 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $8,467,206 | 59,877 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,635,397 | 10,331 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,173,144 | 9,241 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $930,102 | 8,589 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $647,170 | 7,076 | Shares | Sole | 2024-05-09 | |
| No filing history on record for this holder in this stock. | ||||||